ARCHIVES

Senate Committee Approves Additional $400 Million For NCI, $275 Million For FDA.

This article is from The Cancer Letter archive.

Vol. 34 No. 19 | May 16, 2008

Download PDF Visit The Full Archive

Related Articles

Drug Combination Can Block Proteins Preventing Cell Death In Acute Lymphoblastic Leukemia

September 27, 2013

Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival

September 28, 2012

NCI-Approved Clinical Trials

December 31, 2004

International Group Plans Survey On Thrombosis Risk

July 27, 2001

DCE Advisors OK Recompetitions Worth $10 Mil.

July 19, 1991

FDA Approved 88% Of Cancer Applications Since Oncology Office Opened In 2005.

July 3, 2008